BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27329261)

  • 1. Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dog.
    Xie Q; Chen Y; Liu F; Zhong Z; Zhao K; Ling Z; Wang F; Tang X; Wang Z; Liu L; Liu X
    Drug Metab Pharmacokinet; 2016 Aug; 31(4):314-22. PubMed ID: 27329261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
    Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
    J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human.
    Ma XC; Ning J; Ge GB; Liang SC; Wang XL; Zhang BJ; Huang SS; Li JK; Yang L
    Drug Metab Dispos; 2011 Apr; 39(4):675-82. PubMed ID: 21205911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
    Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
    Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human UDP-glucuronosyltransferase isoforms involved in the isofraxidin glucuronidation and assessment of the species differences of the reaction.
    Meng F; Li Y; He G; Ge G; Liu S
    Fitoterapia; 2017 Mar; 117():118-125. PubMed ID: 27915055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes.
    Wang S; Tang X; Yang T; Xu J; Zhang J; Liu X; Liu L
    Xenobiotica; 2019 Feb; 49(2):161-168. PubMed ID: 29375004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human.
    Wang P; Zhao Y; Zhu Y; Sun J; Yerke A; Sang S; Yu Z
    J Pharm Biomed Anal; 2016 Feb; 119():166-74. PubMed ID: 26683990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
    Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
    Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of in vitro metabolites of deoxypodophyllotoxin in human and rat liver microsomes using liquid chromatography/tandem mass spectrometry.
    Lee SK; Jun IH; Yoo HH; Kim JH; Seo YM; Kang MJ; Lee SH; Jeong TC; Kim DH
    Rapid Commun Mass Spectrom; 2008; 22(1):52-8. PubMed ID: 18050240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
    Li W; Zhang J; Wang Y; Hu F; Zhang Y
    Drug Test Anal; 2019 Feb; 11(2):240-249. PubMed ID: 30129284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on metabolic dynamics,metabolic enzyme phenotype and species difference of hepatic and intestinal microsome of psoralidin].
    Qin ZF; Zhang BB; Xing H; Wang PL; Yang J; Zhang XJ; Yao ZH; Yao XS
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3410-3421. PubMed ID: 34396762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of a rifamycin derivative by animal and human liver microsomes, whole blood and expressed human CYP3A isoform.
    Mae T; Hosoe K; Fujii K; Yamashita K; Yamane T; Hidaka T; Ohashi T
    Xenobiotica; 1996 Aug; 26(8):793-802. PubMed ID: 8879143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of deoxypodophyllotoxin from Anthriscus sylvestris on human CYP2C9 and CYP3A4.
    Lee SK; Kim Y; Jin C; Lee SH; Kang MJ; Jeong TC; Jeong SY; Kim DH; Yoo HH
    Planta Med; 2010 May; 76(7):701-4. PubMed ID: 19960413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interspecies Variation in NCMN
    Dai Z; Sun G; Yang J; Hou J; Zhou P; Xie W; Ge G; Sun X; Yang L
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31366067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
    Obach RS
    Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the species differences in CES1A-mediated hydrolytic metabolism by using a bioluminescence substrate.
    Jin Q; Li Z; Zhang MJ; Liu WC; Zou LW; Sui H; Wang DD; Tang QF; Ge GB
    Chem Biol Interact; 2022 Dec; 368():110197. PubMed ID: 36174736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat.
    Swinney DC
    Drug Metab Dispos; 1990; 18(6):859-65. PubMed ID: 1981529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.